InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: hutschi post# 230419

Sunday, 08/16/2015 12:46:39 PM

Sunday, August 16, 2015 12:46:39 PM

Post# of 346015
hutschi, interesting HOPE : )

here is another scenario and how difficult is it for a patient to even realize they are on a certain drug vs another in a trial? Some drugs make you pi$$ much more then the placebo or vice versa, some drugs make you feel like $hit and some do not, heck some even reduce MDSC's and some do not and maybe it is time that patients even realize that you can go get a blood work done somewhere else and have ones MDSC's measured before and during Sunrise (that is what I would do..)

now, if MDSC's are not deceased by the 2-3 week period into Sunrise and other side affects continue, I guess they can just drop out of the trial saying that they don't like the side affects and I wonder how many ask to be dropped out based on if they are in the Bavi+Docetaxel arm vs the Docetaxel+placebo arm ?

So many questions everyone is asking and I think Big Pharma, FDA, SEC and Federal Authorities are all aware that people are pi$$ed off that their PS Targeting company was saboted and not going home unless PS Targeting is FDA approved across the board.

time will tell


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News